Showing results (111-120 of 125) with videos related to
Sort By:
Pageof 13
Clinical Transplantation|December 18, 2009
Short-term renal outcomes in African American and Caucasian donors following live kidney donationA Reeves-Daniel, B I Freedman, D Assimos, et al.The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|December 24, 1997
National cancer clinical trials: children have equal access; adolescents do notW A Bleyer, H Tejeda, S B Murphy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study GroupW A Bleyer, H N Sather, H J Nickerson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106P S Gaynon, P G Steinherz, W A Bleyer, et al.Lancet (London, England)|October 22, 1988
Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study GroupP S Gaynon, P G Steinherz, W A Bleyer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapyT W Pendergrass, J M Milstein, J R Geyer, et al.Medical and Pediatric Oncology|December 1, 1996
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer GroupS A Feig, M M Ames, H N Sather, et al.The Journal of Bone and Joint Surgery. British Volume|January 1, 1982
Improved three-year disease-free survival in osteogenic sarcomaW A Bleyer, J E Haas, P Feigl, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group StudyS M Blaney, M N Needle, A Gillespie, et al.Cancer|February 6, 1998
Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer GroupP G Steinherz, P S Gaynon, J C Breneman, et al.Pageof 13